| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 57.3× | −1.7× | |
| Price / Book | 44.6× | 2.0× | |
| Price / Sales | 18.2× | 3.9× | |
| Price / Free cash flow | 131.9× | −1.6× | |
| EV / EBITDA | 43.6× | −1.2× | |
| Earnings yield | 1.7% | −14.6% | |
| Free cash flow yield | 0.8% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $253.64 | −0.75% | $611.25B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $283.89 | −0.54% | $501.67B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $402.58 | +0.29% | $361.35B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.65 | −0.89% | $356.88B | 19.7× | 34.7% | +73.5% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.38 | −0.16% | $278.19B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $165.15 | −0.16% | $256.13B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $675.84 | −2.05% | $249.89B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $427.97 | −1.05% | $231.37B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $154.43 | −1.13% | $191.49B | 22.8× | 37.5% | +32.0% |
ABNYSE:ABTAbbott Laboratories · 🇺🇸 NYSE | $103.74 | −1.10% | $180.7B | 28.0× | 12.5% | −19.0% |
